Evidence map›Paper›PMID 30849190›Full record

ArticleCA: a cancer journal for clinicians2019

Implementing personalized pathways for cancer follow-up care in the United States: Proceedings from an American Cancer Society-American Society of Clinical Oncology summit.

Catherine M Alfano, Deborah K Mayer, Smita Bhatia, Jane Maher, Jessica M Scott, Larissa Nekhlyudov, Janette K Merrill, Tara O Henderson

Abstract readConference Proceedings
In one paragraph

Article in CA: a cancer journal for clinicians, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Synthesis of clinical practice guidelines and recommendations for breast cancer survivorship care: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  2. Facilitators and barriers to shared primary and specialist cancer care: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Beyond demographics: physical activity as a key behavioral marker for identifying the guidance-seeking profile to guide precision survivorship care.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  7. Healthcare professionals' perceived barriers and facilitators of risk-stratified follow-up care in lung cancer: a qualitative study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Long-term breast cancer survivors: experiences, needs, and proposals for person-centred care.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Profiling of psychoneurological symptoms in newly diagnosed head and neck cancer patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Catherine M AlfanoVice President, Survivorship, American Cancer Society Inc, Washington, DC.ORCID 0000-0001-6488-2186
Deborah K MayerDirector of Cancer Survivorship and Professor, University of North Carolina at Chapel Hill School of Nursing, Chapel Hill, NC.
Smita BhatiaDirector, Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham (UAB) School of Medicine, Professor and Vice Chair for Outcomes, Department of Pediatrics, UAB; and Associate Director for Cancer Outcomes Research, UAB Comprehensive Cancer Center, UAB, Birmingham, AL.
Jane MaherJoint Chief Medical Officer, Macmillan Cancer Support, London, United Kingdom.
Jessica M ScottPrincipal Investigator, Memorial Sloan Kettering Cancer Center, New York, NY.
Larissa NekhlyudovAssociate Professor, Brigham & Women's Hospital, Harvard Medical School, Boston, MA.
Janette K MerrillAssociate Director, Health Policy, American Society of Clinical Oncology, Alexandria, VA.
Tara O HendersonAssociate Professor, Department of Pediatrics, and Medical Director, Childhood Cancer Survivor Center, The University of Chicago Comer Children's Hospital, Chicago, IL.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

A new approach to cancer follow-up care is necessary to meet the needs of cancer survivors while dealing with increasing volume and provider shortages, knowledge gaps, and costs to both health care systems and patients. An approach that triages patients to personalized follow-up care pathways, depending on the type(s) and level(s) of resources needed for patients' long-term care, is in use in the United Kingdom and other countries and has been shown to meet patients' needs, more efficiently use the health care system, and reduce costs. Recognizing that testing and implementing a similar personalized approach to cancer follow-up care in the United States will require a multipronged strategy, the American Cancer Society and the American Society of Clinical Oncology convened a summit in January 2018 to identify the needed steps to move this work from concept to implementation. The summit identified 4 key strategies going forward: 1) developing a candidate model (or models) of care delivery; 2) building the case for implementation by conducting studies modeling the effects of personalized pathways of follow-up care on patient outcomes, workforce and health care resources, and utilization and costs; 3) creating consensus-based guidelines to guide the delivery of personalized care pathways; and 4) identifying and filling research gaps to develop and implement needed care changes. While these national strategies are pursued, oncology and primary care providers can lay the groundwork for implementation by assessing their patients' risk of recurrence and the chronic and late effects of cancer as well as other health care needs and resources available for care and by considering triaging patients accordingly, referring patients to appropriate specialized survivorship clinics as these are developed, helping to support patients who are capable of self-managing their health, setting expectations with patients from diagnosis onward for the need for follow-up in primary care and/or a survivorship clinic, and improving coordination of care between oncology and primary care.

Indexed as

AftercarePrecision MedicineAmerican Cancer SocietyHumansMedical OncologyNeoplasmsUnited Statescancer survivorsdisease managementevidence-based practicepolicyrisk assessmentsurvivorship

Identifiers

PMID30849190
PMCPMC7376887

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.